Strattera Controlled Symptoms of ADHD With Minimal Effect on Sleep
Added
May-2004
NEW YORK, May 4 /PRNewswire-FirstCall/ -- Twice daily treatment with Strattera®
(atomoxetine HCl), approved for the treatment of Attention- Deficit/Hyperactivity
Disorder (ADHD), showed children with ADHD fell asleep nearly 10 times faster
(3.36 minutes versus 30.14 minutes, p<.001) compared to three-times daily
treatment with methylphenidate, according to study results presented today
at the 157th annual meeting of the American Psychiatric Association. The results
were based on comparisons before treatment and during treatment.
Parent and child diaries also showed that children on Strattera had less difficulty
getting out of bed in the morning versus children taking methylphenidate.
Additionally, parent diaries showed children on Strattera were less irritable
compared to methylphenidate.
"Sleep difficulties related to methylphenidate therapy can represent
a considerable source of ...
FULL STORY